Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading ->
Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading ->
HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries.  However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading ->
For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned.  In 2022-2023, RSV was the […] Continue reading ->
A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading ->
While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading ->
Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies.   WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading ->
India will contribute $85 million over a decade to the World Health Organization’s Global Traditional Medicine Center, the WHO announced. The center, located in the Indian western city of Jamnagar, aims to strengthen the evidence base for traditional medicine and provide data on related policies, practices and public use. The donation is part of a […] Continue reading ->
The Argentina-based biotech firm,  Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s  Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading ->